Yicheng Goto Pharmaceuticals Co., Ltd
This firm is named on 2 FDA import alerts in China. Shipments from a listed firm may be detained at the port without physical examination. The oldest listing dates to 29 April 2016, the newest to 10 January 2018.
- 2import alerts now
- 10years since the first listing
- 0listings come off
- 30 Augustcopy checked, 2026
Every alert naming this firm
Source: FDA import alerts, mirrored 30 August 2026 · newest listing first
| Alert | Subject | Country | Listed since |
|---|---|---|---|
| 66-40 | Drugs From Firms Which Have Not Met Drug GMPs55----- · 56----- · 58----- · 60----- · 61----- · 62----- | China | 10 January 20188 yr |
| 66-66 | APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.12261U--99 · 64G--99 | China | 29 April 201610 yr |
Product classes covered
A listing does not cover everything the factory makes — it covers the FDA product codes named on the alert. These are the codes attached to this firm, with the class FDA prints for each.
| Code | Product class |
|---|---|
| 55----- | Pharm Necess & Ctnr For Drug/Bio |
| 56----- | Antibiotics (Human/Animal) |
| 58----- | Human and Animal Therapeutic Biologic and Biosimilar Drugs |
| 60----- | Human and Animal Drugs |
| 61U--99 | Anti-Estrogen N.E.C. |
| 64G--99 | Estrogen N.E.C. |
Why this matters under FSVP
If you import this firm's food into the United States, the FSVP rule makes you re-evaluate the supplier when new information comes to light about its performance. An import alert listing is exactly that kind of information. What FSVP requires and where this fits.
This page exists because the firm was on more than one alert when we first saw it, on 30 August 2026. It stays even after the listings come off, because FDA does not publish removals. What moved lately · check another supplier.